LIDOCAINE, MENTHOL

LIDOCAINE, MENTHOL was reported 50286 times

LIDOCAINE, MENTHOL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 628 0.5913
1 INSPIRATORY CAPACITY DECREASED 88 0.3177
2 SLEEP DISORDER THERAPY 61 0.3081
3 APPENDICOLITH 89 0.2300
4 ANALGESIC THERAPY 61 0.1900
5 DRUG THERAPY 61 0.1799
6 MATERNAL EXPOSURE DURING DELIVERY 157 0.1584
7 TOXIC ANTERIOR SEGMENT SYNDROME 170 0.1558
8 INFUSION SITE DISCHARGE 220 0.1254
9 METHAEMOGLOBINAEMIA 246 0.1062
10 LAGOPHTHALMOS 43 0.1051
11 INFUSION SITE MASS 97 0.0892
12 INFUSION SITE URTICARIA 59 0.0881
13 INFUSION SITE BRUISING 179 0.0828
14 INFUSION SITE PRURITUS 258 0.0817
15 INFUSION SITE HAEMORRHAGE 243 0.0738
16 CAUDA EQUINA SYNDROME 50 0.0651
17 PROCEDURAL HYPOTENSION 52 0.0611
18 INFUSION SITE RASH 83 0.0605
19 INFUSION SITE SWELLING 378 0.0600
20 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 62 0.0584
21 INFUSION SITE DISCOMFORT 60 0.0579
22 ANAESTHETIC COMPLICATION NEUROLOGICAL 51 0.0563
23 ANAESTHETIC COMPLICATION 145 0.0539
24 INFUSION SITE NODULE 50 0.0520
25 INFUSION SITE WARMTH 60 0.0489
26 KOUNIS SYNDROME 109 0.0480
27 INFUSION SITE IRRITATION 59 0.0459
28 NEPHROGENIC ANAEMIA 209 0.0451
29 HYPERPARATHYROIDISM SECONDARY 111 0.0443
30 DEVICE INFUSION ISSUE 109 0.0439
31 INFUSION SITE ERYTHEMA 370 0.0438
32 HYPERPHOSPHATAEMIA 94 0.0437
33 INFUSION SITE PAIN 556 0.0431
34 INCORRECT DRUG ADMINISTRATION RATE 178 0.0418
35 INFUSION SITE EXTRAVASATION 248 0.0398
36 HYPERTHERMIA MALIGNANT 57 0.0383
37 ADMINISTRATION SITE PAIN 44 0.0382
38 MULTIPLE ALLERGIES 295 0.0376
39 VASOPLEGIA SYNDROME 61 0.0372
40 RETINAL VASCULITIS 44 0.0369
41 BLOOD PHOSPHORUS INCREASED 92 0.0337
42 INSURANCE ISSUE 509 0.0333
43 INFUSION SITE REACTION 91 0.0304
44 SEASONAL ALLERGY 420 0.0296
45 PULSELESS ELECTRICAL ACTIVITY 120 0.0287
46 INFUSION SITE INDURATION 41 0.0276
47 CORNEAL OEDEMA 62 0.0276
48 TOTAL LUNG CAPACITY DECREASED 42 0.0263
49 VENTRICULAR FIBRILLATION 277 0.0249
50 REBOUND ACID HYPERSECRETION 75 0.0248
51 DERMATITIS CONTACT 273 0.0239
52 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 78 0.0235
53 OBSTRUCTION 91 0.0228
54 RESPIRATORY TRACT INFECTION VIRAL 53 0.0227
55 STRESS CARDIOMYOPATHY 129 0.0222
56 VENTRICULAR TACHYCARDIA 351 0.0212
57 IRON DEFICIENCY 94 0.0209
58 LUNG OPACITY 55 0.0208
59 PARAPLEGIA 60 0.0208
60 END STAGE RENAL DISEASE 375 0.0205
61 PULSE ABSENT 96 0.0202
62 ANAPHYLACTIC SHOCK 517 0.0200
63 POOR VENOUS ACCESS 204 0.0197
64 EAR INFECTION 518 0.0194
65 RESPIRATORY TRACT INFECTION 505 0.0194
66 CHRONIC SINUSITIS 72 0.0192
67 SINUSITIS 1953 0.0190
68 INGROWING NAIL 43 0.0182
69 TYPE I HYPERSENSITIVITY 62 0.0176
70 AORTIC STENOSIS 61 0.0175
71 GENERALISED TONIC-CLONIC SEIZURE 289 0.0174
72 VENTRICULAR HYPOKINESIA 56 0.0174
73 STATUS EPILEPTICUS 196 0.0173
74 PRODUCT DISTRIBUTION ISSUE 159 0.0171
75 CARDIOGENIC SHOCK 244 0.0170
76 HYPOPHOSPHATAEMIA 125 0.0169
77 ANIMAL BITE 45 0.0169
78 OTITIS MEDIA 55 0.0166
79 UPPER RESPIRATORY TRACT INFECTION 769 0.0166
80 LUMBAR SPINAL STENOSIS 48 0.0164
81 APPLICATION SITE BURN 80 0.0162
82 MYASTHENIA GRAVIS 130 0.0161
83 VASCULAR DEVICE INFECTION 73 0.0161
84 SKIN ABRASION 76 0.0161
85 APNOEA 125 0.0160
86 HAEMODYNAMIC INSTABILITY 122 0.0160
87 RHINOVIRUS INFECTION 62 0.0159
88 RETINAL ARTERY OCCLUSION 40 0.0158
89 CATHETER SITE PAIN 41 0.0158
90 PRODUCT ADHESION ISSUE 563 0.0157
91 BLOOD URIC ACID INCREASED 89 0.0154
92 STREPTOCOCCAL INFECTION 85 0.0153
93 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 78 0.0152
94 BUNDLE BRANCH BLOCK LEFT 64 0.0151
95 VENTRICULAR ARRHYTHMIA 55 0.0150
96 HYPERCAPNIA 45 0.0149
97 ANHEDONIA 392 0.0149
98 DEAFNESS NEUROSENSORY 49 0.0149
99 LARYNGOSPASM 40 0.0149
100 SKIN INFECTION 165 0.0147
101 ANAPHYLACTIC REACTION 805 0.0146
102 RENAL INJURY 427 0.0144
103 SINUS TACHYCARDIA 204 0.0144
104 STRIDOR 41 0.0139
105 GASTROENTERITIS VIRAL 249 0.0138
106 MULTI-ORGAN FAILURE 236 0.0136
107 ARTHRITIS BACTERIAL 56 0.0136
108 TENDERNESS 142 0.0136
109 PHARYNGITIS STREPTOCOCCAL 146 0.0135
110 APPENDICITIS 126 0.0135
111 PROCTALGIA 86 0.0134
112 MENINGITIS ASEPTIC 60 0.0134
113 BRONCHIECTASIS 90 0.0133
114 ATELECTASIS 129 0.0133
115 FEAR 356 0.0132
116 SPINAL CORD COMPRESSION 51 0.0131
117 PARADOXICAL DRUG REACTION 48 0.0130
118 SPINAL OSTEOARTHRITIS 113 0.0128
119 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 65 0.0128
120 VENTRICULAR EXTRASYSTOLES 132 0.0127
121 SKIN LACERATION 137 0.0126
122 RESPIRATORY DEPRESSION 153 0.0125
123 RESPIRATORY ACIDOSIS 49 0.0125
124 INTERVERTEBRAL DISC DEGENERATION 114 0.0123
125 TOOTH INFECTION 162 0.0123
126 ENDOPHTHALMITIS 73 0.0122
127 LIVE BIRTH 101 0.0121
128 GASTROINTESTINAL INFECTION 108 0.0120
129 HYPOXIA 423 0.0120
130 BACTERIAL INFECTION 224 0.0120
131 PRODUCT ADMINISTRATION INTERRUPTED 94 0.0120
132 UNRESPONSIVE TO STIMULI 308 0.0119
133 CARDIAC ARREST 985 0.0119
134 NYSTAGMUS 63 0.0119
135 BRONCHITIS 859 0.0116
136 SINUS BRADYCARDIA 112 0.0116
137 HORDEOLUM 49 0.0113
138 BRADYCARDIA 598 0.0113
139 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 193 0.0112
140 HYPERLIPIDAEMIA 134 0.0112
141 ARTHRITIS INFECTIVE 52 0.0112
142 TROPONIN INCREASED 85 0.0112
143 DECUBITUS ULCER 91 0.0112
144 BREATH SOUNDS ABNORMAL 55 0.0111
145 NEURALGIA 271 0.0111
146 NEUROTOXICITY 195 0.0111
147 KIDNEY INFECTION 218 0.0111
148 SINUS DISORDER 219 0.0110
149 RESPIRATORY SYNCYTIAL VIRUS INFECTION 96 0.0110
150 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 97 0.0110
151 BRAIN OEDEMA 138 0.0109
152 CHRONIC KIDNEY DISEASE 829 0.0109
153 PNEUMONIA FUNGAL 43 0.0109
154 VIRAL INFECTION 361 0.0108
155 PSEUDOMONAS INFECTION 92 0.0107
156 TORSADE DE POINTES 84 0.0107
157 SENSORY LOSS 86 0.0107
158 MYDRIASIS 136 0.0106
159 EYE INFECTION 119 0.0105
160 HYPERVOLAEMIA 52 0.0105
161 PERIPHERAL VASCULAR DISORDER 54 0.0105
162 POST PROCEDURAL INFECTION 85 0.0104
163 MENTAL STATUS CHANGES 290 0.0104
164 WEIGHT FLUCTUATION 108 0.0103
165 GLUCOSE TOLERANCE IMPAIRED 61 0.0103
166 NORMAL NEWBORN 56 0.0103
167 TRIGEMINAL NEURALGIA 41 0.0102
168 BRONCHOSPASM 145 0.0102
169 POST PROCEDURAL COMPLICATION 195 0.0101
170 CANDIDA INFECTION 171 0.0101
171 TOOTH ABSCESS 103 0.0101
172 PRE-EXISTING CONDITION IMPROVED 63 0.0101
173 FOOD POISONING 54 0.0101
174 PHARYNGITIS 125 0.0101
175 IMMUNE THROMBOCYTOPENIA 46 0.0100
176 HEPARIN-INDUCED THROMBOCYTOPENIA 49 0.0099
177 RHINITIS ALLERGIC 44 0.0099
178 STAPHYLOCOCCAL INFECTION 326 0.0099
179 INFUSION RELATED REACTION 655 0.0099
180 CIRCULATORY COLLAPSE 168 0.0099
181 RALES 57 0.0098
182 MYOCLONUS 117 0.0098
183 LEFT VENTRICULAR DYSFUNCTION 65 0.0097
184 HYPOAESTHESIA ORAL 146 0.0097
185 VARICOSE VEIN 50 0.0097
186 CONCUSSION 74 0.0095
187 CYSTITIS 304 0.0095
188 PROCEDURAL COMPLICATION 73 0.0095
189 LOCALISED INFECTION 230 0.0095
190 SKIN NECROSIS 49 0.0094
191 MENINGITIS 63 0.0094
192 CARDIOTOXICITY 84 0.0094
193 DIVERTICULUM INTESTINAL 41 0.0094
194 NERVE INJURY 103 0.0093
195 HYPERAESTHESIA 76 0.0092
196 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 504 0.0092
197 ARTHROPOD BITE 68 0.0092
198 ESCHERICHIA INFECTION 75 0.0091
199 FOOD ALLERGY 70 0.0091
200 RIB FRACTURE 185 0.0090
201 RENAL FAILURE 1185 0.0089
202 STAPHYLOCOCCAL SEPSIS 44 0.0089
203 ECONOMIC PROBLEM 135 0.0089
204 SPINAL COLUMN STENOSIS 42 0.0089
205 URINARY TRACT INFECTION 1514 0.0089
206 INJURY 622 0.0088
207 RENAL TUBULAR NECROSIS 86 0.0088
208 ACUTE RESPIRATORY FAILURE 168 0.0087
209 SCAR 149 0.0087
210 CELLULITIS 433 0.0086
211 SUPRAVENTRICULAR TACHYCARDIA 82 0.0086
212 GINGIVITIS 46 0.0085
213 ATRIOVENTRICULAR BLOCK COMPLETE 57 0.0085
214 ROTATOR CUFF SYNDROME 109 0.0085
215 THERMAL BURN 60 0.0084
216 NERVE COMPRESSION 78 0.0084
217 HAEMORRHOIDS 164 0.0084
218 SCIATICA 134 0.0084
219 FACIAL PAIN 75 0.0084
220 LIGAMENT SPRAIN 83 0.0084
221 COVID-19 PNEUMONIA 99 0.0084
222 ACUTE PULMONARY OEDEMA 47 0.0084
223 MIOSIS 67 0.0083
224 MUSCLE STRAIN 72 0.0083
225 PRODUCTIVE COUGH 396 0.0083
226 IMPAIRED GASTRIC EMPTYING 113 0.0083
227 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 45 0.0083
228 LYMPHOEDEMA 57 0.0082
229 LIMB INJURY 223 0.0082
230 MUSCULOSKELETAL CHEST PAIN 127 0.0082
231 BEHAVIOUR DISORDER 44 0.0081
232 BENIGN PROSTATIC HYPERPLASIA 42 0.0081
233 GRAND MAL CONVULSION 75 0.0081
234 HYPOTENSION 1628 0.0081
235 FIBROMYALGIA 197 0.0081
236 ILLNESS 834 0.0081
237 TACHYPNOEA 110 0.0081
238 ORAL CANDIDIASIS 106 0.0080
239 IRON DEFICIENCY ANAEMIA 74 0.0080
240 POSTOPERATIVE WOUND INFECTION 54 0.0080
241 COVID-19 1402 0.0080
242 HYPERKERATOSIS 44 0.0080
243 DRUG LEVEL INCREASED 132 0.0080
244 RESPIRATORY TRACT CONGESTION 126 0.0079
245 UPPER-AIRWAY COUGH SYNDROME 65 0.0079
246 THERAPY PARTIAL RESPONDER 123 0.0079
247 ECCHYMOSIS 54 0.0079
248 FACIAL PARALYSIS 67 0.0079
249 SPINAL PAIN 92 0.0078
250 VITREOUS FLOATERS 77 0.0078
251 RENAL CYST 62 0.0078
252 HIATUS HERNIA 101 0.0078
253 FOOT FRACTURE 147 0.0077
254 SKIN WARM 45 0.0077
255 CLOSTRIDIUM DIFFICILE COLITIS 82 0.0077
256 FAILURE TO THRIVE 40 0.0077
257 JOINT EFFUSION 53 0.0077
258 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 401 0.0077
259 OSTEOMYELITIS 139 0.0077
260 EXOSTOSIS 70 0.0077
261 MULTIPLE ORGAN DYSFUNCTION SYNDROME 217 0.0077
262 TACHYCARDIA 678 0.0076
263 ANAL INCONTINENCE 68 0.0076
264 FEBRILE NEUTROPENIA 500 0.0075
265 SLEEP APNOEA SYNDROME 143 0.0075
266 HAND FRACTURE 53 0.0075
267 TOXICITY TO VARIOUS AGENTS 1261 0.0075
268 COMPRESSION FRACTURE 40 0.0075
269 SENSITIVE SKIN 55 0.0074
270 INJECTION SITE DISCHARGE 40 0.0074
271 OSTEOPENIA 112 0.0074
272 CYANOSIS 116 0.0074
273 AUTOIMMUNE DISORDER 71 0.0073
274 SINUS CONGESTION 98 0.0072
275 ULCER 115 0.0072
276 CARPAL TUNNEL SYNDROME 101 0.0072
277 OBSTRUCTIVE AIRWAYS DISORDER 80 0.0072
278 PNEUMOTHORAX 114 0.0072
279 INADEQUATE ANALGESIA 61 0.0072
280 VITAMIN D DEFICIENCY 70 0.0072
281 RETINAL HAEMORRHAGE 51 0.0072
282 CARDIOMEGALY 88 0.0071
283 OXYGEN SATURATION DECREASED 402 0.0071
284 PARAESTHESIA ORAL 103 0.0071
285 UNEVALUABLE EVENT 539 0.0071
286 RESPIRATORY DISTRESS 196 0.0071
287 EYELID PTOSIS 72 0.0071
288 DIPLOPIA 184 0.0071
289 BLOOD CALCIUM INCREASED 62 0.0071
290 APPLICATION SITE PAIN 155 0.0070
291 POST-TRAUMATIC STRESS DISORDER 47 0.0070
292 BODY TEMPERATURE INCREASED 143 0.0070
293 INCONTINENCE 74 0.0070
294 NECK PAIN 391 0.0070
295 HEREDITARY ANGIOEDEMA 75 0.0070
296 GOUT 125 0.0070
297 WRONG PRODUCT ADMINISTERED 47 0.0069
298 MASS 97 0.0069
299 FLANK PAIN 65 0.0069
300 INTERVERTEBRAL DISC PROTRUSION 150 0.0069
301 ASPIRATION 75 0.0068
302 BURSITIS 83 0.0068
303 SMALL INTESTINAL OBSTRUCTION 84 0.0068
304 DYSARTHRIA 256 0.0068
305 ENCEPHALOPATHY 167 0.0068
306 PREMATURE DELIVERY 108 0.0068
307 SPINAL COMPRESSION FRACTURE 56 0.0068
308 SPINAL DISORDER 64 0.0068
309 PNEUMONIA BACTERIAL 62 0.0067
310 SEROTONIN SYNDROME 129 0.0067
311 MALNUTRITION 75 0.0067
312 BRAIN FOG 105 0.0067
313 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 52 0.0067
314 ORAL DISORDER 49 0.0067
315 IMPAIRED QUALITY OF LIFE 96 0.0067
316 SEPSIS 744 0.0067
317 WOUND INFECTION 73 0.0067
318 FUNGAL INFECTION 222 0.0067
319 PULMONARY MASS 99 0.0066
320 NEPHROPATHY 62 0.0066
321 APPLICATION SITE VESICLES 43 0.0066
322 HYPERCHOLESTEROLAEMIA 64 0.0066
323 JOINT DISLOCATION 70 0.0066
324 DRUG TOXICITY 90 0.0066
325 THERAPY NON-RESPONDER 294 0.0065
326 MUSCULOSKELETAL DISCOMFORT 112 0.0065
327 LARYNGEAL OEDEMA 40 0.0065
328 BACTERAEMIA 77 0.0065
329 DIVERTICULUM 46 0.0065
330 PULMONARY OEDEMA 289 0.0064
331 BODY HEIGHT DECREASED 69 0.0064
332 ACCIDENT 77 0.0064
333 HYPOALBUMINAEMIA 50 0.0064
334 TRICUSPID VALVE INCOMPETENCE 51 0.0064
335 HERPES ZOSTER 368 0.0064
336 PNEUMONIA ASPIRATION 160 0.0064
337 BLOOD PRESSURE ABNORMAL 127 0.0064
338 PULMONARY CONGESTION 84 0.0064
339 CLOSTRIDIUM DIFFICILE INFECTION 139 0.0064
340 INFLUENZA 710 0.0064
341 PNEUMONIA 2060 0.0064
342 OEDEMA 345 0.0064
343 DIVERTICULITIS 176 0.0063
344 PHARYNGEAL SWELLING 62 0.0063
345 MIGRAINE 604 0.0063
346 SPUTUM DISCOLOURED 60 0.0063
347 MOTOR DYSFUNCTION 64 0.0063
348 POOR QUALITY SLEEP 135 0.0063
349 PLEURAL EFFUSION 380 0.0062
350 RESPIRATION ABNORMAL 43 0.0062
351 LUNG INFILTRATION 55 0.0062
352 JOINT INJURY 133 0.0062
353 EAR PAIN 121 0.0062
354 CONTUSION 599 0.0062
355 CARDIO-RESPIRATORY ARREST 260 0.0062
356 RESPIRATORY FAILURE 453 0.0062
357 RHINITIS 50 0.0062
358 DELIRIUM 215 0.0062
359 BRAIN INJURY 62 0.0062
360 UROSEPSIS 57 0.0062
361 SHOCK 142 0.0062
362 ORAL PAIN 138 0.0062
363 BACK INJURY 67 0.0062
364 BLOOD PRESSURE DECREASED 409 0.0061
365 HAEMATOCRIT DECREASED 122 0.0061
366 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1103 0.0061
367 SPINAL OPERATION 75 0.0061
368 CYTOKINE RELEASE SYNDROME 122 0.0061
369 PARALYSIS 87 0.0061
370 RESPIRATORY ARREST 167 0.0061
371 EYE MOVEMENT DISORDER 41 0.0060
372 ASCITES 176 0.0060
373 PAPULE 42 0.0060
374 ACUTE KIDNEY INJURY 911 0.0059
375 NEPHROLITHIASIS 273 0.0059
376 EMPHYSEMA 60 0.0059
377 INABILITY TO AFFORD MEDICATION 59 0.0059
378 APHTHOUS ULCER 46 0.0059
379 BLOOD ALBUMIN DECREASED 47 0.0059
380 MITRAL VALVE INCOMPETENCE 67 0.0059
381 BACK PAIN 1375 0.0059
382 PRODUCT DOSE OMISSION ISSUE 1739 0.0059
383 PELVIC FRACTURE 46 0.0059
384 BACK DISORDER 96 0.0059
385 ATAXIA 70 0.0059
386 NASOPHARYNGITIS 1084 0.0059
387 ANKLE FRACTURE 91 0.0059
388 PROCEDURAL PAIN 163 0.0059
389 EXTRASYSTOLES 41 0.0059
390 MICTURITION URGENCY 67 0.0059
391 RIGHT VENTRICULAR FAILURE 41 0.0058
392 METABOLIC ACIDOSIS 187 0.0058
393 SKIN ULCER 151 0.0058
394 ELECTROCARDIOGRAM QT PROLONGED 210 0.0058
395 NODULE 76 0.0058
396 LEUKOCYTOSIS 105 0.0058
397 LOW BIRTH WEIGHT BABY 46 0.0058
398 HOSPICE CARE 57 0.0058
399 CONJUNCTIVITIS 107 0.0058
400 SEIZURE 666 0.0058
401 DYSPNOEA EXERTIONAL 217 0.0058
402 PULMONARY HYPERTENSION 120 0.0058
403 OSTEOARTHRITIS 244 0.0057
404 APHONIA 80 0.0057
405 INFECTION 826 0.0057
406 BLINDNESS TRANSIENT 42 0.0057
407 SPINAL FRACTURE 114 0.0057
408 JOINT RANGE OF MOTION DECREASED 76 0.0057
409 OSTEOPOROSIS 233 0.0057
410 PREMATURE BABY 170 0.0056
411 BLADDER DISORDER 56 0.0056
412 DISABILITY 111 0.0056
413 MAJOR DEPRESSION 41 0.0056
414 DENTAL CARIES 62 0.0056
415 DEVICE RELATED INFECTION 86 0.0056
416 DEPRESSED LEVEL OF CONSCIOUSNESS 221 0.0056
417 GROIN PAIN 49 0.0056
418 CHILLS 654 0.0056
419 SWELLING 522 0.0056
420 PAIN IN JAW 158 0.0056
421 ATRIOVENTRICULAR BLOCK 43 0.0056
422 BLOOD PRESSURE DIASTOLIC DECREASED 41 0.0055
423 TOOTHACHE 100 0.0055
424 HYPERTHERMIA 42 0.0055
425 ORAL HERPES 107 0.0055
426 HYDRONEPHROSIS 41 0.0055
427 HEAD INJURY 173 0.0055
428 RENAL FAILURE CHRONIC 42 0.0055
429 MUSCLE RIGIDITY 65 0.0054
430 ARTERIOSCLEROSIS 51 0.0054
431 RESPIRATORY DISORDER 162 0.0054
432 ATRIAL FIBRILLATION 526 0.0054
433 ABSCESS 86 0.0054
434 ATRIAL FLUTTER 43 0.0054
435 TUBULOINTERSTITIAL NEPHRITIS 101 0.0054
436 LOWER RESPIRATORY TRACT INFECTION 245 0.0054
437 TOOTH DISORDER 119 0.0053
438 RENAL FAILURE ACUTE 227 0.0053
439 MYOSITIS 48 0.0053
440 EJECTION FRACTION DECREASED 83 0.0053
441 BLOOD MAGNESIUM DECREASED 46 0.0053
442 ACUTE CORONARY SYNDROME 44 0.0053
443 PURPURA 47 0.0053
444 BLOOD IRON DECREASED 63 0.0053
445 PAIN 3261 0.0053
446 HEPATOMEGALY 52 0.0053
447 SUBSTANCE ABUSE 43 0.0053
448 HYPOKALAEMIA 243 0.0053
449 DIZZINESS POSTURAL 51 0.0053
450 WRIST FRACTURE 63 0.0053
451 BLOOD POTASSIUM DECREASED 158 0.0052
452 FALL 1747 0.0052
453 GASTROOESOPHAGEAL REFLUX DISEASE 422 0.0052
454 LOSS OF CONSCIOUSNESS 671 0.0052
455 OROPHARYNGEAL PAIN 483 0.0052
456 HEART RATE DECREASED 183 0.0052
457 BLOOD UREA INCREASED 87 0.0052
458 HEMIPARESIS 88 0.0052
459 MYOCARDIAL ISCHAEMIA 59 0.0052
460 ELECTROLYTE IMBALANCE 60 0.0052
461 ANXIETY 1467 0.0051
462 PULMONARY THROMBOSIS 56 0.0051
463 HYPERTENSIVE CRISIS 57 0.0051
464 MUSCLE TIGHTNESS 83 0.0051
465 MUSCLE TWITCHING 118 0.0051
466 RETINAL DETACHMENT 47 0.0051
467 HYPOMAGNESAEMIA 71 0.0051
468 IRRITABLE BOWEL SYNDROME 109 0.0051
469 NEUTROPHIL COUNT INCREASED 52 0.0051
470 PYELONEPHRITIS 44 0.0051
471 LETHARGY 292 0.0051
472 UPPER LIMB FRACTURE 101 0.0051
473 ILEUS 63 0.0051
474 POST PROCEDURAL HAEMORRHAGE 59 0.0051
475 HYPONATRAEMIA 284 0.0050
476 STOMATITIS 304 0.0050
477 CARDIOMYOPATHY 74 0.0050
478 OROPHARYNGEAL DISCOMFORT 45 0.0050
479 BLOOD CALCIUM DECREASED 56 0.0050
480 HAEMATOMA 129 0.0050
481 CATARACT 296 0.0050
482 INTENTIONAL PRODUCT USE ISSUE 435 0.0050
483 FOOT DEFORMITY 55 0.0050
484 URINARY INCONTINENCE 147 0.0050
485 DRUG INTERACTION 787 0.0050
486 LIMB DISCOMFORT 153 0.0049
487 BONE DISORDER 90 0.0049
488 GENERALISED OEDEMA 61 0.0049
489 EYE INFLAMMATION 47 0.0049
490 HAEMOPTYSIS 137 0.0049
491 NEUROPATHY PERIPHERAL 465 0.0049
492 LYMPHADENOPATHY 173 0.0049
493 EMOTIONAL DISTRESS 591 0.0049
494 URINARY RETENTION 162 0.0049
495 ACCIDENTAL OVERDOSE 177 0.0048
496 CYST 60 0.0048
497 BLOOD PRESSURE INCREASED 739 0.0048
498 COMA 230 0.0048
499 PALLOR 131 0.0048
500 SUBARACHNOID HAEMORRHAGE 49 0.0048
501 TOOTH FRACTURE 53 0.0048
502 PYREXIA 1663 0.0048
503 NASAL CONGESTION 282 0.0048
504 HYPERTENSION 1016 0.0048
505 COUGH 1340 0.0048
506 DISCOMFORT 291 0.0048
507 BLOOD TEST ABNORMAL 67 0.0048
508 HYPERKALAEMIA 167 0.0048
509 OESOPHAGITIS 52 0.0048
510 LYMPHOCYTE COUNT DECREASED 84 0.0047
511 PSYCHOLOGICAL TRAUMA 41 0.0047
512 TINNITUS 218 0.0047
513 PHOTOPHOBIA 89 0.0047
514 RESTLESS LEGS SYNDROME 86 0.0047
515 COLD SWEAT 83 0.0047
516 ROAD TRAFFIC ACCIDENT 197 0.0047
517 QUALITY OF LIFE DECREASED 63 0.0047
518 APPLICATION SITE ERYTHEMA 123 0.0047
519 BASAL CELL CARCINOMA 73 0.0047
520 INCREASED TENDENCY TO BRUISE 43 0.0047
521 MUCOSAL INFLAMMATION 122 0.0047
522 PRESYNCOPE 113 0.0046
523 SCRATCH 49 0.0046
524 BURNING SENSATION 325 0.0046
525 OCULAR DISCOMFORT 52 0.0046
526 CARDIAC MURMUR 40 0.0046
527 COAGULOPATHY 77 0.0046
528 WHEEZING 274 0.0046
529 EXPOSURE DURING PREGNANCY 287 0.0046
530 DISSEMINATED INTRAVASCULAR COAGULATION 65 0.0046
531 BLOOD SODIUM DECREASED 87 0.0046
532 HYPOTONIA 46 0.0046
533 HEADACHE 2866 0.0046
534 RENAL IMPAIRMENT 384 0.0046
535 LIVER FUNCTION TEST INCREASED 98 0.0046
536 SCAB 52 0.0046
537 RESTLESSNESS 166 0.0045
538 PRODUCT USE IN UNAPPROVED INDICATION 1123 0.0045
539 BLOOD URINE PRESENT 86 0.0045
540 RENAL PAIN 48 0.0045
541 LOWER LIMB FRACTURE 87 0.0045
542 SEPTIC SHOCK 197 0.0045
543 CONSTIPATION 987 0.0045
544 NEOPLASM 52 0.0045
545 DEHYDRATION 603 0.0045
546 WOUND 126 0.0045
547 HERNIA 87 0.0045
548 TOXIC EPIDERMAL NECROLYSIS 68 0.0045
549 CHROMATURIA 101 0.0045
550 HEART RATE INCREASED 443 0.0045
551 HALLUCINATION, VISUAL 94 0.0044
552 DERMATITIS ALLERGIC 56 0.0044
553 FULL BLOOD COUNT ABNORMAL 47 0.0044
554 SKIN DISCOLOURATION 204 0.0044
555 GASTROINTESTINAL DISORDER 397 0.0044
556 HYPOAESTHESIA 663 0.0044
557 PERIPHERAL SWELLING 681 0.0044
558 ABDOMINAL DISTENSION 461 0.0044
559 HYPOTHYROIDISM 141 0.0044
560 THROMBOSIS 355 0.0044
561 ANGIOEDEMA 195 0.0044
562 COMPLICATION ASSOCIATED WITH DEVICE 64 0.0044
563 FLUID RETENTION 224 0.0044
564 DYSURIA 162 0.0044
565 BLISTER 247 0.0044
566 ERYTHEMA MULTIFORME 41 0.0044
567 DEFORMITY 41 0.0044
568 MATERNAL EXPOSURE DURING PREGNANCY 390 0.0044
569 EYE PAIN 246 0.0044
570 SQUAMOUS CELL CARCINOMA 41 0.0044
571 APHASIA 131 0.0043
572 RED BLOOD CELL COUNT DECREASED 124 0.0043
573 DEVICE OCCLUSION 61 0.0043
574 VISUAL ACUITY REDUCED 143 0.0043
575 CONFUSIONAL STATE 695 0.0043
576 TRANSFUSION 45 0.0043
577 APPLICATION SITE RASH 59 0.0043
578 BLOOD CHOLESTEROL INCREASED 200 0.0043
579 ARTHRITIS 336 0.0043
580 MOUTH ULCERATION 90 0.0043
581 CHEST PAIN 791 0.0043
582 EPISTAXIS 319 0.0043
583 TENDONITIS 66 0.0043
584 SWOLLEN TONGUE 133 0.0043
585 CHEST DISCOMFORT 436 0.0043
586 SOMNOLENCE 857 0.0043
587 ASTHMA 480 0.0042
588 ACUTE RESPIRATORY DISTRESS SYNDROME 75 0.0042
589 NERVOUS SYSTEM DISORDER 132 0.0042
590 DYSTONIA 82 0.0042
591 INTRAOCULAR PRESSURE INCREASED 54 0.0042
592 NEEDLE ISSUE 123 0.0042
593 SLEEP DISORDER 297 0.0042
594 GLAUCOMA 81 0.0042
595 HEART RATE IRREGULAR 95 0.0042
596 WHITE BLOOD CELL COUNT INCREASED 161 0.0042
597 INFLUENZA LIKE ILLNESS 345 0.0042
598 TASTE DISORDER 85 0.0042
599 ANAEMIA 799 0.0042
600 OEDEMA PERIPHERAL 510 0.0042
601 MUSCULAR WEAKNESS 475 0.0042
602 DRY MOUTH 339 0.0042
603 IMPAIRED HEALING 137 0.0042
604 SARS-COV-2 TEST POSITIVE 55 0.0042
605 ARRHYTHMIA 197 0.0042
606 VERTIGO 253 0.0041
607 MUSCULOSKELETAL PAIN 217 0.0041
608 SPEECH DISORDER 217 0.0041
609 EYE DISCHARGE 43 0.0041
610 EATING DISORDER 88 0.0041
611 TENDON RUPTURE 51 0.0041
612 WEIGHT DECREASED 1153 0.0041
613 SYNCOPE 413 0.0041
614 ACUTE MYOCARDIAL INFARCTION 121 0.0041
615 PULMONARY EMBOLISM 389 0.0041
616 EAR DISCOMFORT 42 0.0041
617 LIP SWELLING 136 0.0041
618 LUNG DISORDER 200 0.0041
619 SKIN DISORDER 136 0.0041
620 DYSPHAGIA 386 0.0041
621 NIGHT SWEATS 131 0.0041
622 PAIN IN EXTREMITY 1197 0.0041
623 COLITIS 154 0.0041
624 AGITATION 298 0.0041
625 VOMITING 1896 0.0040
626 PETECHIAE 42 0.0040
627 MACULAR DEGENERATION 48 0.0040
628 HAIR COLOUR CHANGES 50 0.0040
629 FATIGUE 3122 0.0040
630 SECRETION DISCHARGE 50 0.0040
631 RHINORRHOEA 258 0.0040
632 DYSPHONIA 233 0.0040
633 GALLBLADDER DISORDER 71 0.0040
634 BLOOD PRESSURE FLUCTUATION 95 0.0040
635 THYROID DISORDER 61 0.0040
636 DYSPNOEA 2232 0.0039
637 TREMOR 653 0.0039
638 NAUSEA 3110 0.0039
639 MENTAL DISORDER 171 0.0039
640 DYSKINESIA 159 0.0039
641 HEAD DISCOMFORT 69 0.0039
642 DRUG INTOLERANCE 375 0.0039
643 FEELING COLD 108 0.0039
644 TEMPERATURE INTOLERANCE 40 0.0039
645 SKIN LESION 106 0.0039
646 LUNG INFECTION 60 0.0039
647 PRODUCT ADMINISTRATION ERROR 78 0.0039
648 PRODUCT USE ISSUE 725 0.0039
649 TOOTH EXTRACTION 48 0.0039
650 FACE OEDEMA 65 0.0039
651 PERICARDIAL EFFUSION 89 0.0038
652 RETCHING 82 0.0038
653 CHOLELITHIASIS 126 0.0038
654 PRODUCT AVAILABILITY ISSUE 87 0.0038
655 BLOOD POTASSIUM INCREASED 62 0.0038
656 MUSCLE ATROPHY 48 0.0038
657 HYPOKINESIA 55 0.0038
658 BLINDNESS 154 0.0038
659 CHOLECYSTITIS 45 0.0038
660 BALANCE DISORDER 326 0.0038
661 CHOLECYSTECTOMY 43 0.0038
662 MUSCLE SPASMS 690 0.0038
663 MUSCULOSKELETAL STIFFNESS 329 0.0038
664 PRODUCT QUALITY ISSUE 509 0.0037
665 BLOOD PRESSURE SYSTOLIC INCREASED 73 0.0037
666 ALTERED STATE OF CONSCIOUSNESS 81 0.0037
667 DISORIENTATION 148 0.0037
668 SWELLING FACE 243 0.0037
669 PARAESTHESIA 587 0.0037
670 DECREASED APPETITE 866 0.0037
671 URTICARIA 624 0.0037
672 BREAST CANCER METASTATIC 40 0.0037
673 GASTRITIS 98 0.0037
674 DRUG EFFECT LESS THAN EXPECTED 55 0.0037
675 RED BLOOD CELL SEDIMENTATION RATE INCREASED 41 0.0037
676 PULMONARY FIBROSIS 71 0.0037
677 DYSSTASIA 108 0.0037
678 DEEP VEIN THROMBOSIS 240 0.0037
679 FULL BLOOD COUNT DECREASED 74 0.0037
680 MUSCLE SPASTICITY 45 0.0037
681 POISONING 46 0.0037
682 SNEEZING 82 0.0037
683 BEDRIDDEN 48 0.0036
684 HEPATIC STEATOSIS 68 0.0036
685 HAEMATURIA 125 0.0036
686 INJECTION SITE EXTRAVASATION 45 0.0036
687 PRODUCT DOSE OMISSION IN ERROR 103 0.0036
688 PHOTOSENSITIVITY REACTION 60 0.0036
689 DERMATITIS 76 0.0036
690 ADRENAL INSUFFICIENCY 44 0.0036
691 SKIN REACTION 51 0.0036
692 BONE DENSITY DECREASED 113 0.0036
693 ABDOMINAL PAIN 839 0.0036
694 ERYTHEMA 741 0.0036
695 HYPERSOMNIA 103 0.0036
696 GAIT INABILITY 120 0.0036
697 PULMONARY ARTERIAL HYPERTENSION 52 0.0036
698 TRANSIENT ISCHAEMIC ATTACK 121 0.0036
699 ARTHROPATHY 199 0.0036
700 IMMUNE SYSTEM DISORDER 47 0.0036
701 MEDICATION ERROR 198 0.0036
702 SEDATION 93 0.0035
703 METASTASES TO LUNG 41 0.0035
704 SURGERY 208 0.0035
705 C-REACTIVE PROTEIN INCREASED 129 0.0035
706 ASPARTATE AMINOTRANSFERASE INCREASED 188 0.0035
707 DEPRESSION 804 0.0035
708 GINGIVAL BLEEDING 48 0.0035
709 OBESITY 56 0.0035
710 HIP FRACTURE 113 0.0035
711 THROAT TIGHTNESS 95 0.0035
712 PERICARDITIS 59 0.0035
713 RASH MACULO-PAPULAR 78 0.0035
714 DIABETES MELLITUS 267 0.0035
715 FEEDING DISORDER 71 0.0035
716 DIZZINESS 1745 0.0035
717 PERIPHERAL COLDNESS 48 0.0035
718 COGNITIVE DISORDER 163 0.0035
719 PRODUCT PRESCRIBING ISSUE 76 0.0035
720 GAIT DISTURBANCE 667 0.0035
721 JOINT STIFFNESS 91 0.0035
722 CORONARY ARTERY DISEASE 105 0.0035
723 BONE PAIN 202 0.0034
724 MADAROSIS 40 0.0034
725 RECTAL HAEMORRHAGE 148 0.0034
726 HAIR TEXTURE ABNORMAL 46 0.0034
727 INTENTIONAL DOSE OMISSION 98 0.0034
728 PANCYTOPENIA 192 0.0034
729 METASTASES TO BONE 56 0.0034
730 PREGNANCY 68 0.0034
731 HYPERSENSITIVITY 629 0.0034
732 BLOOD ALKALINE PHOSPHATASE INCREASED 84 0.0034
733 AMNESIA 220 0.0034
734 ARTHRALGIA 1402 0.0034
735 INCORRECT PRODUCT ADMINISTRATION DURATION 73 0.0034
736 THROAT IRRITATION 151 0.0034
737 HYPERHIDROSIS 433 0.0034
738 PRODUCT PREPARATION ERROR 69 0.0034
739 SKIN CANCER 72 0.0033
740 ASTHENIA 1257 0.0033
741 DRUG ABUSE 278 0.0033
742 METASTASES TO CENTRAL NERVOUS SYSTEM 43 0.0033
743 ACTIVITIES OF DAILY LIVING IMPAIRED 66 0.0033
744 BLOOD BILIRUBIN INCREASED 90 0.0033
745 GASTRIC ULCER 63 0.0033
746 RASH PRURITIC 179 0.0033
747 MENTAL IMPAIRMENT 80 0.0033
748 RENAL DISORDER 153 0.0033
749 INTENTIONAL PRODUCT MISUSE 287 0.0033
750 HAEMOGLOBIN DECREASED 336 0.0033
751 PNEUMONITIS 89 0.0033
752 INTESTINAL OBSTRUCTION 123 0.0033
753 FLUID OVERLOAD 47 0.0032
754 INFLAMMATION 166 0.0032
755 VISION BLURRED 441 0.0032
756 HALLUCINATION 242 0.0032
757 PALPITATIONS 376 0.0032
758 RASH 1399 0.0032
759 HYPOPHAGIA 82 0.0032
760 POLLAKIURIA 133 0.0032
761 LACRIMATION INCREASED 96 0.0032
762 CARDIAC FAILURE CONGESTIVE 255 0.0032
763 MALAISE 1392 0.0032
764 BLOOD TRIGLYCERIDES INCREASED 56 0.0032
765 BLOOD CREATININE INCREASED 206 0.0032
766 TREATMENT FAILURE 261 0.0031
767 CONVULSION 180 0.0031
768 DIARRHOEA 2024 0.0031
769 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 150 0.0031
770 STEVENS-JOHNSON SYNDROME 69 0.0031
771 DEAFNESS 81 0.0031
772 TOOTH LOSS 64 0.0031
773 DRY EYE 154 0.0031
774 OSTEONECROSIS OF JAW 76 0.0031
775 OFF LABEL USE 2683 0.0031
776 WEIGHT INCREASED 686 0.0031
777 MOBILITY DECREASED 220 0.0031
778 CENTRAL NERVOUS SYSTEM LESION 42 0.0031
779 DIALYSIS 43 0.0030
780 PARANOIA 52 0.0030
781 CARDIAC DISORDER 282 0.0030
782 PLATELET COUNT DECREASED 319 0.0030
783 SENSORY DISTURBANCE 48 0.0030
784 CONDITION AGGRAVATED 908 0.0030
785 ORTHOSTATIC HYPOTENSION 52 0.0030
786 DISTURBANCE IN ATTENTION 161 0.0030
787 FEELING HOT 183 0.0030
788 PRODUCT USE COMPLAINT 47 0.0030
789 ALANINE AMINOTRANSFERASE INCREASED 183 0.0030
790 MEMORY IMPAIRMENT 409 0.0030
791 HYPERTHYROIDISM 43 0.0030
792 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 210 0.0029
793 IMMUNODEFICIENCY 44 0.0029
794 INSOMNIA 786 0.0029
795 THROMBOCYTOPENIA 330 0.0029
796 GENERAL PHYSICAL HEALTH DETERIORATION 340 0.0029
797 DRUG INEFFECTIVE 3858 0.0029
798 MULTIPLE FRACTURES 48 0.0029
799 MYALGIA 495 0.0029
800 HAEMORRHAGE 304 0.0029
801 OVERDOSE 626 0.0029
802 RASH PAPULAR 65 0.0029
803 JOINT SWELLING 350 0.0029
804 DYSPEPSIA 285 0.0029
805 PSYCHOMOTOR HYPERACTIVITY 48 0.0029
806 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 53 0.0029
807 PRURITUS 1108 0.0029
808 HEPATIC CIRRHOSIS 54 0.0029
809 FLUSHING 292 0.0029
810 NERVOUSNESS 150 0.0029
811 SUBDURAL HAEMATOMA 41 0.0029
812 NEUTROPHIL COUNT DECREASED 116 0.0028
813 PLASMA CELL MYELOMA 111 0.0028
814 RASH ERYTHEMATOUS 136 0.0028
815 FEELING ABNORMAL 679 0.0028
816 ANGINA PECTORIS 81 0.0028
817 CARDIAC FAILURE 226 0.0028
818 HIP ARTHROPLASTY 43 0.0028
819 IMPAIRED WORK ABILITY 60 0.0028
820 RASH MACULAR 98 0.0028
821 OSTEONECROSIS 92 0.0028
822 PANIC ATTACK 102 0.0028
823 PRODUCT PHYSICAL ISSUE 56 0.0028
824 ABDOMINAL DISCOMFORT 465 0.0028
825 PELVIC PAIN 50 0.0027
826 HYPOCALCAEMIA 52 0.0027
827 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 64 0.0027
828 INCORRECT ROUTE OF DRUG ADMINISTRATION 98 0.0027
829 EYE DISORDER 89 0.0027
830 NEUTROPENIA 368 0.0027
831 SKIN HAEMORRHAGE 40 0.0027
832 FLATULENCE 153 0.0027
833 WHITE BLOOD CELL COUNT DECREASED 291 0.0027
834 EOSINOPHILIA 47 0.0027
835 ABDOMINAL PAIN UPPER 550 0.0027
836 FOETAL EXPOSURE DURING PREGNANCY 216 0.0027
837 SYSTEMIC LUPUS ERYTHEMATOSUS 94 0.0026
838 MOVEMENT DISORDER 85 0.0026
839 DELUSION 41 0.0026
840 THERAPY INTERRUPTED 188 0.0026
841 HOT FLUSH 197 0.0026
842 TRANSAMINASES INCREASED 58 0.0026
843 AGEUSIA 65 0.0026
844 HAEMATEMESIS 66 0.0026
845 CEREBRAL HAEMORRHAGE 93 0.0026
846 CEREBROVASCULAR ACCIDENT 439 0.0026
847 VISUAL IMPAIRMENT 321 0.0026
848 RHEUMATOID ARTHRITIS 292 0.0026
849 HEPATIC FAILURE 77 0.0026
850 LIVER DISORDER 112 0.0025
851 KNEE ARTHROPLASTY 53 0.0025
852 OCULAR HYPERAEMIA 119 0.0025
853 GASTROINTESTINAL HAEMORRHAGE 209 0.0025
854 THERAPEUTIC RESPONSE UNEXPECTED 112 0.0025
855 ADVERSE DRUG REACTION 224 0.0025
856 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 42 0.0025
857 APPLICATION SITE PRURITUS 56 0.0025
858 SUICIDAL IDEATION 225 0.0025
859 GLOSSODYNIA 55 0.0025
860 HYPERGLYCAEMIA 89 0.0024
861 SYNOVITIS 44 0.0024
862 DEMENTIA 68 0.0024
863 DRUG ERUPTION 43 0.0024
864 CRYING 88 0.0024
865 NO ADVERSE EVENT 438 0.0024
866 FEELING JITTERY 46 0.0024
867 THERAPEUTIC PRODUCT EFFECT DECREASED 108 0.0024
868 THIRST 43 0.0024
869 ALOPECIA 471 0.0024
870 DYSGEUSIA 178 0.0024
871 EYE SWELLING 89 0.0024
872 NEOPLASM PROGRESSION 83 0.0024
873 INTENTIONAL OVERDOSE 153 0.0024
874 INTERNATIONAL NORMALISED RATIO INCREASED 68 0.0024
875 MIDDLE INSOMNIA 44 0.0024
876 EPILEPSY 72 0.0024
877 SKIN FISSURES 46 0.0024
878 ISCHAEMIC STROKE 42 0.0024
879 DISEASE PROGRESSION 274 0.0023
880 INJECTION SITE SWELLING 177 0.0023
881 CHOKING 45 0.0023
882 FAECES DISCOLOURED 50 0.0023
883 EMOTIONAL DISORDER 71 0.0023
884 SKIN EXFOLIATION 194 0.0023
885 HOSPITALISATION 352 0.0023
886 BLOOD GLUCOSE DECREASED 110 0.0023
887 PRESCRIBED OVERDOSE 44 0.0023
888 PROTEINURIA 43 0.0023
889 MUSCULOSKELETAL DISORDER 43 0.0023
890 MALIGNANT NEOPLASM PROGRESSION 231 0.0023
891 THINKING ABNORMAL 42 0.0023
892 GASTRIC DISORDER 77 0.0022
893 TYPE 2 DIABETES MELLITUS 75 0.0022
894 SKIN IRRITATION 102 0.0022
895 PSORIATIC ARTHROPATHY 90 0.0022
896 ABDOMINAL PAIN LOWER 56 0.0022
897 RHABDOMYOLYSIS 92 0.0022
898 WITHDRAWAL SYNDROME 92 0.0022
899 INJECTION SITE MASS 81 0.0022
900 HYPOACUSIS 94 0.0022
901 PSYCHOTIC DISORDER 64 0.0022
902 HYPOGLYCAEMIA 105 0.0022
903 LACTIC ACIDOSIS 70 0.0022
904 THERAPEUTIC RESPONSE DECREASED 131 0.0022
905 DEPRESSED MOOD 114 0.0022
906 EYE IRRITATION 124 0.0022
907 ECZEMA 112 0.0021
908 MELAENA 47 0.0021
909 HAEMATOCHEZIA 117 0.0021
910 BLOOD CREATINE PHOSPHOKINASE INCREASED 61 0.0021
911 DEVICE DISLOCATION 90 0.0021
912 NEOPLASM MALIGNANT 138 0.0021
913 COMPLICATION OF DEVICE INSERTION 41 0.0021
914 HEPATIC ENZYME INCREASED 140 0.0021
915 INJECTION SITE PRURITUS 136 0.0020
916 THERAPEUTIC RESPONSE SHORTENED 67 0.0020
917 EXPIRED PRODUCT ADMINISTERED 67 0.0020
918 LABORATORY TEST ABNORMAL 59 0.0020
919 INJECTION SITE PAIN 613 0.0020
920 DEATH 1718 0.0020
921 TREATMENT NONCOMPLIANCE 109 0.0020
922 MOOD ALTERED 54 0.0020
923 EXTRAPYRAMIDAL DISORDER 49 0.0020
924 CARDIOVASCULAR DISORDER 50 0.0020
925 PANCREATITIS 104 0.0020
926 NIGHTMARE 68 0.0020
927 INJECTION SITE ERYTHEMA 242 0.0019
928 ILL-DEFINED DISORDER 117 0.0019
929 FREQUENT BOWEL MOVEMENTS 52 0.0019
930 CEREBRAL INFARCTION 47 0.0019
931 IRRITABILITY 115 0.0019
932 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 56 0.0019
933 LEUKOPENIA 95 0.0019
934 AGGRESSION 95 0.0019
935 RASH GENERALISED 49 0.0019
936 WRONG TECHNIQUE IN DRUG USAGE PROCESS 68 0.0019
937 PRODUCT DOSE OMISSION 122 0.0019
938 INJECTION SITE BRUISING 148 0.0019
939 DRY SKIN 241 0.0018
940 DRUG ADMINISTRATION ERROR 55 0.0018
941 DRUG EFFECT INCOMPLETE 65 0.0018
942 HEPATIC FUNCTION ABNORMAL 66 0.0018
943 LIVER INJURY 43 0.0018
944 CONTRAINDICATED PRODUCT ADMINISTERED 53 0.0017
945 MYOCARDIAL INFARCTION 305 0.0017
946 PAIN OF SKIN 47 0.0017
947 INJECTION SITE REACTION 120 0.0017
948 MULTIPLE SCLEROSIS 83 0.0017
949 EYE PRURITUS 58 0.0017
950 DEVICE ISSUE 153 0.0017
951 DRUG EFFECT DECREASED 91 0.0017
952 INCORRECT DOSE ADMINISTERED 383 0.0017
953 VAGINAL HAEMORRHAGE 72 0.0017
954 FEMUR FRACTURE 51 0.0016
955 HEPATITIS 42 0.0016
956 COMPLETED SUICIDE 131 0.0016
957 ADVERSE EVENT 144 0.0016
958 ACCIDENTAL EXPOSURE TO PRODUCT 161 0.0016
959 ABNORMAL BEHAVIOUR 60 0.0015
960 INTERSTITIAL LUNG DISEASE 73 0.0015
961 DEVICE LEAKAGE 64 0.0015
962 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 299 0.0015
963 BLOOD GLUCOSE INCREASED 277 0.0015
964 SUICIDE ATTEMPT 88 0.0014
965 ABNORMAL DREAMS 40 0.0014
966 LIVER FUNCTION TEST ABNORMAL 42 0.0014
967 DRUG-INDUCED LIVER INJURY 45 0.0014
968 PRODUCT SUBSTITUTION ISSUE 81 0.0014
969 MULTIPLE SCLEROSIS RELAPSE 92 0.0013
970 DRUG EXPOSURE DURING PREGNANCY 45 0.0013
971 SKIN BURNING SENSATION 94 0.0013
972 DRUG WITHDRAWAL SYNDROME 113 0.0013
973 THERAPY CESSATION 65 0.0013
974 DISEASE RECURRENCE 58 0.0012
975 INJECTION SITE HAEMORRHAGE 97 0.0012
976 DEVICE BREAKAGE 49 0.0012
977 PSORIASIS 156 0.0012
978 EXTRA DOSE ADMINISTERED 48 0.0012
979 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 40 0.0012
980 ANGER 40 0.0012
981 COLITIS ULCERATIVE 50 0.0011
982 DEVICE MALFUNCTION 78 0.0011
983 LUNG NEOPLASM MALIGNANT 45 0.0011
984 DERMATITIS ATOPIC 57 0.0011
985 DRUG DEPENDENCE 173 0.0011
986 ACNE 72 0.0009
987 DRUG DOSE OMISSION 155 0.0009
988 BREAST CANCER 84 0.0009
989 UNDERDOSE 65 0.0009
990 DEVICE DIFFICULT TO USE 57 0.0009
991 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 54 0.0008
992 PRODUCT STORAGE ERROR 61 0.0007